{
    "2020-07-14": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Eli Lilly (LLY) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Could A $775 Million Roche-Blueprint Deal Unseat Eli Lilly In Cancer?",
                "features": {
                    "keywords": [
                        "Roche",
                        "Blueprint",
                        "Deal",
                        "Eli Lilly",
                        "Cancer"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "FDA Aims to Fast-Track Coronavirus Vaccine: 3 Stocks in Focus",
                "features": {
                    "keywords": [
                        "FDA",
                        "Fast-Track",
                        "Coronavirus",
                        "Vaccine",
                        "Stocks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Pharmas restart drug trials after pandemic-related declines, Medidata finds",
                "features": {
                    "keywords": [
                        "Pharmas",
                        "restart",
                        "drug trials",
                        "pandemic-related declines",
                        "Medidata"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}